Advertisement QuantRx and ALT BioScience to develop periodontal screening product - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

QuantRx and ALT BioScience to develop periodontal screening product

QuantRx Biomedical has entered into a second development and manufacturing agreement with ALT BioScience, to continue the development of their professional periodontal screening product.

This is the second oral healthcare product in their portfolio. The products will be available for distribution in the dental and consumer marketplaces with applications including halitosis, gingivitis, and periodontal disease.

Cindy Horton, vice president-diagnostics at QuantRx, said: “We feel this partnership gives company an entry point to the fast growing oral care market. We feel this collaboration will greatly enhance our revenue base.”